These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12603582)

  • 21. Hyperlipidemia: diagnostic and therapeutic perspectives.
    Ballantyne CM; Grundy SM; Oberman A; Kreisberg RA; Havel RJ; Frost PH; Haffner SM
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2089-112. PubMed ID: 10852435
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of hyperlipidemia].
    Keller C
    Wien Med Wochenschr; 1994; 144(12-13):330-2. PubMed ID: 8650939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gene mutations in familial hyperlipidemias].
    Yamamoto A
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():661-9. PubMed ID: 11351667
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis of familial hypercholesterolemia using DNA haplotype analysis in three large families with two hyperlipidemic parents.
    Schuster H; Keller C; Wolfram G; Zöllner N
    Ann Nutr Metab; 1992; 36(2):79-86. PubMed ID: 1354952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment of severe hyperlipidemia].
    Tonstad S; Leren TP; Ose L
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4241-4. PubMed ID: 9441469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial disorders of lipid metabolism in childhood].
    Herrmann W; Biermann J
    Z Arztl Fortbild (Jena); 1986; 80(17):725-8. PubMed ID: 3811401
    [No Abstract]   [Full Text] [Related]  

  • 27. Summary of the national guidelines for the diagnosis and management of lipid disorders in Taiwan. The experts panel.
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):1-14. PubMed ID: 7712390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia.
    Noto D; Cefalù AB; Barraco G; Martino E; Fayer F; Minà M; Montali A; Arca M; Averna M; Martino F
    Pediatr Res; 2010 Feb; 67(2):200-4. PubMed ID: 20091938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recommendations of the Belgian Lipid Club for the diagnosis and treatment of hyperlipidemias: summary for the practitioner].
    Ducobu J; Scheen AJ
    Rev Med Liege; 2000 May; 55(5):360-6. PubMed ID: 10941298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary management of hyperlipidemia in women.
    Mosca LJ
    J Womens Health Gend Based Med; 2002 Jun; 11(5):423-32. PubMed ID: 12165159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia.
    Solanas-Barca M; de Castro-Orós I; Mateo-Gallego R; Cofán M; Plana N; Puzo J; Burillo E; Martín-Fuentes P; Ros E; Masana L; Pocoví M; Civeira F; Cenarro A
    Atherosclerosis; 2012 Jun; 222(2):449-55. PubMed ID: 22481068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
    Bello-Chavolla OY; Kuri-García A; Ríos-Ríos M; Vargas-Vázquez A; Cortés-Arroyo JE; Tapia-González G; Cruz-Bautista I; Aguilar-Salinas CA
    Rev Invest Clin; 2018; 70(5):224-236. PubMed ID: 30307446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of familial dysalbuminemic hyperthyroxinemia with familial hypercholesterolemia and multiple lipoprotein type hyperlipidemia.
    Premachandra BN; Wolfe B; Williams IK
    Am J Med; 1988 Feb; 84(2):345-51. PubMed ID: 3407659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic aspects of dyslipoproteinemias].
    de Gennes JL
    Bull Acad Natl Med; 1985 Jun; 169(6):729-34. PubMed ID: 3002561
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physiopathology of primary hyperlipidemias].
    Luc G; Turpin G; De Gennes JL
    Ann Med Interne (Paris); 1986; 137(2):155-66. PubMed ID: 3521430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperlipidemias].
    Windler E; Beil FU; Greten H
    Internist (Berl); 1991 May; 32(5):W37-48. PubMed ID: 1869397
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possible relationship between overweightness and prevalence of hyperlipemia in the children of patients with heterozygote familial hypercholesterolemia and combined familial hyperlipemia].
    Jansen S; Zambrana JL; López Miranda J; Blanco A; Blanco J; Jiménez Perepérez JA; Espino A; Pérez Jiménez F
    Med Clin (Barc); 1995 Jun; 105(3):85-8. PubMed ID: 7603116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
    Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
    Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.